Hypnotic drugs.
D000368:Aged; D001463:Barbiturates / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D002697:Chloral Hydrate / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D004569:Electroencephalography; D005021:Ethylamines / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D008702:Methaqualone / Q000627:therapeutic use; D008875:Middle Aged; D010242:Paraldehyde / Q000627:therapeutic use; D010881:Piperidones / Q000627:therapeutic use; D012890:Sleep; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000209:etiology; D012895:Sleep, REM
D001463:Barbiturates; D001552:Benzazepines; D005021:Ethylamines; D006993:Hypnotics and Sedatives; D010881:Piperidones; D005461:Fluorine; D002697:Chloral Hydrate; D008702:Methaqualone; D010242:Paraldehyde